Pharmaniaga Berhad (KLSE:PHARMA)

Pharmaniaga Berhad Revenue

Pharmaniaga Berhad had revenue of 1.18B MYR in the quarter ending March 31, 2026, with 11.67% growth. This brings the company's revenue in the last twelve months to 4.05B, up 5.22% year-over-year. In the year 2025, Pharmaniaga Berhad had annual revenue of 3.93B with 4.48% growth.

• Revenue (ttm): 4.05B
• Revenue Growth: +5.22%
• P/S Ratio: 0.40
• Revenue / Employee: 1.16M
• Employees: 3,502
• Market Cap: 1.64B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.93B	168.27M	4.48%
Dec 31, 2024	3.76B	355.00M	10.43%
Dec 31, 2023	3.40B	-76.45M	-2.20%
Dec 31, 2022	3.48B	-1.33B	-27.71%
Dec 31, 2021	4.82B	2.09B	76.69%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 19, 2026

Data Sources Report a data error